Sub menu

 

 

Guerbet Australia

Regulatory activities for this sponsor.

Type

Date

2 result(s) found, displaying 1 to 2

  • Elucirem and Vueway

    Australian public assessment report (AusPar)
    Elucirem/Vueway (gadopiclenol) is indicated in adults and children aged 2 years and older for contrast-enhanced magnetic resonance imaging (MRI) to detect and visualise lesions with abnormal blood brain barrier or abnormal vascularity in the central nervous system (brain, spine, and associated tissues) and the body (head and neck, thorax, abdomen, pelvis and musculoskeletal system).

  • AusPAR: Iodised oil

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Iodised oil